- Current report filing (8-K)
July 01 2009 - 9:35AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 OR 15(d) of the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported):
|
July
1, 2009
|
BIO-BRIDGE
SCIENCE, INC.
|
(Exact
name of registrant as specified in its
charter)
|
Delaware
|
|
20-1802936
|
(State
or other jurisdiction of incorporation)
|
(Commission
File Number)
|
(IRS
Employer Identification No.)
|
|
|
|
1211
West 22nd Street, Suite 615, Oak Brook, Illinois
|
60523
|
(Address
of principal executive offices)
|
(Zip
Code)
|
|
|
|
Registrant’s
telephone number, including area code:
|
630-928-0869
|
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (see General Instruction A.2. below):
[
] Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
[
] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240.14a-12)
[
] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))
[
] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))
This
Form 8-K and other reports filed by the Registrant from time to time with the
Securities and Exchange Commission (collectively the “Filings”) contain forward
looking statements and information that are based upon beliefs of, and
information currently available to, the Registrant’s management as well as
estimates and assumptions made by the Registrant’s management. When
used in the Filings the words “anticipate”, “believe”, “estimate”, “expect”,
“future”, “intend”, “plan” or the negative of these terms and similar
expressions as they relate to the Registrant or the Registrant’s management
identify forward looking statements. Such statements reflect the
current view of the Registrant with respect to future events and are subject to
risks, uncertainties, assumptions and other factors relating to the Registrant’s
industry, operations and results of operations and any businesses that may be
acquired by the Registrant. Should one or more of these risks or
uncertainties materialize, or should the underlying assumptions prove incorrect,
actual results may differ significantly from those anticipated, believed,
estimated, expected, intended or planned.
Item
8.01 Other Events.
As used
in this report, "we", "us", "our" or "the Company" refer to Bio-Bridge Science,
Inc., a Delaware corporation and its subsidiaries.
On July
1, 2009, we issued a press release on the Company’s completion of acquisition of
assets. A copy of the press release is attached hereto as Exhibit
99.1.
Item
9.01 Financial Statements and Exhibits
(d) Exhibits.
Exhibit Number
|
|
Description
|
|
|
|
99.1
|
|
Press
release dated July 1, 2009
|
|
|
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
|
BIO-BRIDGE
SCIENCE, INC.
|
|
|
|
Date:
July
1, 2009
|
By:
|
|
/s/ Liang Qiao, MD.
|
Name
|
|
Liang
Qiao, MD.
|
Title:
|
|
Chief
Executive Officer
|
Bio Bridge Science (CE) (USOTC:BGES)
Historical Stock Chart
From Jun 2024 to Jul 2024
Bio Bridge Science (CE) (USOTC:BGES)
Historical Stock Chart
From Jul 2023 to Jul 2024